Cargando…
Rapid Emergence of Potentially Transmissible Severe Acute Respiratory Syndrome Coronavirus 2 With Resistance to Combination Monoclonal Antibody Therapy
Prolonged coronavirus disease 2019 may generate new viral variants. We report an immunocompromised patient treated with monoclonal antibodies who experienced rebound of viral RNA and emergence of an antibody-resistant (>1000-fold) variant containing 5 mutations in the spike gene. The mutant virus...
Autores principales: | Jacobs, Jana L, Haidar, Ghady, Naqvi, Asma, McCormick, Kevin D, Sobolewski, Michele, Treat, Benjamin R, Heaps, Amy L, Simpson, Jordan, Kramer, Kailey Hughes, McCreary, Erin, Bariola, J Ryan, Klamar-Blain, Cynthia, Macatangay, Bernard J C, Dimitrov, Dimiter, Li, Wei, Marino, Christopher C, Raptis, Anastasios, Sethi, Rahil, Chandran, Uma, Barratt-Boyes, Simon, Parikh, Urvi M, Mellors, John W |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10230564/ https://www.ncbi.nlm.nih.gov/pubmed/37265667 http://dx.doi.org/10.1093/ofid/ofad278 |
Ejemplares similares
-
Therapy With Allogeneic Severe Acute Respiratory Syndrome Coronavirus-2–Specific T Cells for Persistent Coronavirus Disease 2019 in Immunocompromised Patients
por: Haidar, Ghady, et al.
Publicado: (2023) -
Rapid determination of SARS-CoV-2 antibody neutralization titer using Bio-Rad Bio-Plex correlates strongly with pseudovirus-determined neutralization titer
por: Heaps, Amy L., et al.
Publicado: (2023) -
471. In-Depth Characterization of SARS-CoV-2 Variants Causing Breakthrough COVID-19 Among Hospitalized Immunocompromised (IC) Patients with or without Prior Exposure to Tixagevimab-Cilgavimab (T/C) Pre-Exposure Prophylaxis (PrEP)
por: Haidar, Ghady, et al.
Publicado: (2023) -
Intractable Coronavirus Disease 2019 (COVID-19) and Prolonged Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Replication in a Chimeric Antigen Receptor-Modified T-Cell Therapy Recipient: A Case Study
por: Hensley, Matthew K, et al.
Publicado: (2021) -
951. Implementation and Rapid Uptake of an Antimicrobial Stewardship Clinical Decision Support System Across 19 UPMC Hospitals
por: Ryan Bariola, J, et al.
Publicado: (2022)